CIB2 and neoplasm: The tumor volumes were measured, and tumor weights were calculated at the end of the experiment; tumor weights were increased in CIB2-overexpressed group compared to control, and CIB2-overexpressed group treated with gefitinib showed a decline in tumor weights (Figure 7A, 7B).